191 related articles for article (PubMed ID: 38588409)
21. The oncogenic properties of EWS/WT1 of desmoplastic small round cell tumors are unmasked by loss of p53 in murine embryonic fibroblasts.
Bandopadhayay P; Jabbour AM; Riffkin C; Salmanidis M; Gordon L; Popovski D; Rigby L; Ashley DM; Watkins DN; Thomas DM; Algar E; Ekert PG
BMC Cancer; 2013 Dec; 13():585. PubMed ID: 24321497
[TBL] [Abstract][Full Text] [Related]
22. Functional Determinants of Cell Cycle Plasticity and Sensitivity to CDK4/6 Inhibition.
Kumarasamy V; Vail P; Nambiar R; Witkiewicz AK; Knudsen ES
Cancer Res; 2021 Mar; 81(5):1347-1360. PubMed ID: 33323381
[TBL] [Abstract][Full Text] [Related]
23. Oncogenic KRAS-associated gene signature defines co-targeting of CDK4/6 and MEK as a viable therapeutic strategy in colorectal cancer.
Pek M; Yatim SMJM; Chen Y; Li J; Gong M; Jiang X; Zhang F; Zheng J; Wu X; Yu Q
Oncogene; 2017 Aug; 36(35):4975-4986. PubMed ID: 28459468
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic pitfalls of differentiating desmoplastic small round cell tumor (DSRCT) from Wilms tumor (WT): overlapping morphologic and immunohistochemical features.
Arnold MA; Schoenfield L; Limketkai BN; Arnold CA
Am J Surg Pathol; 2014 Sep; 38(9):1220-6. PubMed ID: 24832162
[TBL] [Abstract][Full Text] [Related]
25. Functional, chemical genomic, and super-enhancer screening identify sensitivity to cyclin D1/CDK4 pathway inhibition in Ewing sarcoma.
Kennedy AL; Vallurupalli M; Chen L; Crompton B; Cowley G; Vazquez F; Weir BA; Tsherniak A; Parasuraman S; Kim S; Alexe G; Stegmaier K
Oncotarget; 2015 Oct; 6(30):30178-93. PubMed ID: 26337082
[TBL] [Abstract][Full Text] [Related]
26. Selective Immunoreactivity for WT1 Carboxy-Terminus Distinguishes Desmoplastic Small Round Cell Tumor From its Histologic Mimics.
Wong YP; Buckley K; Iwenofu OH; Singhi A; Kahwash SB; Arnold CA; Tan GC; Arnold MA
Pediatr Dev Pathol; 2022; 25(5):504-510. PubMed ID: 35488420
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of cyclin-dependent kinase 4 as a potential therapeutic strategy for treatment of synovial sarcoma.
Li X; Seebacher NA; Garbutt C; Ma H; Gao P; Xiao T; Hornicek FJ; Duan Z
Cell Death Dis; 2018 May; 9(5):446. PubMed ID: 29670090
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of ONC201 in Desmoplastic Small Round Cell Tumor.
Hayes-Jordan AA; Ma X; Menegaz BA; Lamhamedi-Cherradi SE; Kingsley CV; Benson JA; Camacho PE; Ludwig JA; Lockworth CR; Garcia GE; Craig SL
Neoplasia; 2018 May; 20(5):524-532. PubMed ID: 29626752
[TBL] [Abstract][Full Text] [Related]
29. Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma.
AbuHammad S; Cullinane C; Martin C; Bacolas Z; Ward T; Chen H; Slater A; Ardley K; Kirby L; Chan KT; Brajanovski N; Smith LK; Rao AD; Lelliott EJ; Kleinschmidt M; Vergara IA; Papenfuss AT; Lau P; Ghosh P; Haupt S; Haupt Y; Sanij E; Poortinga G; Pearson RB; Falk H; Curtis DJ; Stupple P; Devlin M; Street I; Davies MA; McArthur GA; Sheppard KE
Proc Natl Acad Sci U S A; 2019 Sep; 116(36):17990-18000. PubMed ID: 31439820
[TBL] [Abstract][Full Text] [Related]
30. Biological specificity of CDK4/6 inhibitors: dose response relationship, in vivo signaling, and composite response signature.
Knudsen ES; Hutcheson J; Vail P; Witkiewicz AK
Oncotarget; 2017 Jul; 8(27):43678-43691. PubMed ID: 28620137
[TBL] [Abstract][Full Text] [Related]
31. Desmoplastic Small Round Cell Tumor of the Kidney: Report of a Case, Literature Review, and Comprehensive Discussion of the Distinctive Morphologic, Immunohistochemical, and Molecular Features in the Differential Diagnosis of Small Round Cell Tumors Affecting the Kidney.
Galliani CA; Bisceglia M; Del Giudice A; Cretì G
Adv Anat Pathol; 2020 Nov; 27(6):408-421. PubMed ID: 32804706
[TBL] [Abstract][Full Text] [Related]
32. The EWS-WT1 gene fusion in desmoplastic small round cell tumor.
Gerald WL; Haber DA
Semin Cancer Biol; 2005 Jun; 15(3):197-205. PubMed ID: 15826834
[TBL] [Abstract][Full Text] [Related]
33. MAPK Reliance via Acquired CDK4/6 Inhibitor Resistance in Cancer.
de Leeuw R; McNair C; Schiewer MJ; Neupane NP; Brand LJ; Augello MA; Li Z; Cheng LC; Yoshida A; Courtney SM; Hazard ES; Hardiman G; Hussain MH; Diehl JA; Drake JM; Kelly WK; Knudsen KE
Clin Cancer Res; 2018 Sep; 24(17):4201-4214. PubMed ID: 29739788
[No Abstract] [Full Text] [Related]
34. Clinicopathological features of desmoplastic small round cell tumors: clinical series and literature review.
Wang LL; Ji ZH; Gao Y; Chang H; Sun PP; Li Y
World J Surg Oncol; 2021 Jun; 19(1):193. PubMed ID: 34193155
[TBL] [Abstract][Full Text] [Related]
35. Desmoplastic Small Round Cell Tumors With Atypical Presentations: A Report of 34 Cases.
Al-Ibraheemi A; Broehm C; Tanas MR; Horvai AE; Rubin BP; Cheah AL; Thway K; Fisher C; Bahrami A; Folpe AL; Fritchie KJ
Int J Surg Pathol; 2019 May; 27(3):236-243. PubMed ID: 30522375
[TBL] [Abstract][Full Text] [Related]
36. Preclinical development of G1T38: A novel, potent and selective inhibitor of cyclin dependent kinases 4/6 for use as an oral antineoplastic in patients with CDK4/6 sensitive tumors.
Bisi JE; Sorrentino JA; Jordan JL; Darr DD; Roberts PJ; Tavares FX; Strum JC
Oncotarget; 2017 Jun; 8(26):42343-42358. PubMed ID: 28418845
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and Biological Evaluation of Novel
Song X; Gan Q; Zhang X; Zhang J
Mol Pharm; 2019 Oct; 16(10):4213-4222. PubMed ID: 31424939
[TBL] [Abstract][Full Text] [Related]
38. Targeting Cyclin-Dependent Kinases in Synovial Sarcoma: Palbociclib as a Potential Treatment for Synovial Sarcoma Patients.
Vlenterie M; Hillebrandt-Roeffen MH; Schaars EW; Flucke UE; Fleuren ED; Navis AC; Leenders WP; Versleijen-Jonkers YM; van der Graaf WT
Ann Surg Oncol; 2016 Sep; 23(9):2745-52. PubMed ID: 27334220
[TBL] [Abstract][Full Text] [Related]
39. [Desmoplastic small round cell tumor in children, adolescents and young adults].
de Marcellus C; Sarnacki S; Pierron G; Ranchère-Vince D; Scalabre A; Bolle S; Minard-Colin V; Corradini N; Fayard C; Orbach D
Bull Cancer; 2018 May; 105(5):523-536. PubMed ID: 29576221
[TBL] [Abstract][Full Text] [Related]
40. Anti-cell growth and anti-cancer stem cell activity of the CDK4/6 inhibitor palbociclib in breast cancer cells.
Kishino E; Ogata R; Saitoh W; Koike Y; Ohta Y; Kanomata N; Kurebayashi J
Breast Cancer; 2020 May; 27(3):415-425. PubMed ID: 31823286
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
